JPRN-UMIN000000808已完成未知
Efficacy of entecavir/IFN alpha sequential therapy for HBeAg-positive chronic active hepatitis B - Entecavir/IFN sequential therapy for chronic hepatitis B (B-SHOT study)
Osaka City University Graduate School of Medicine0 个研究点目标入组 60 人开始时间: 2011年9月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. use of lamivudine or any other antiviral agents for hepatitis B within 3 months before the start of therapy 2. presence of lamivudine-resistant YMDD variants 3. clinical signs of decompensated cirrhosis or liver failure 4. other likely causes of chronic liver disease 5. severe complication (poor renal, cardiac, or respiratory function) 6. women who are possibly pregnant, expectant mothers, and lactating mothers
研究者
相似试验
招募中
不适用
Efficacy and safety of Entecavir/PEG-IFN-alpha sequential therapy for chronic active hepatitis BJPRN-UMIN000006943Department of Hepatology, Osaka City University Graduate School of Medicine50
招募中
不适用
Efficacy of preceding administration of Entecavir with PEG-IFN-alfa2a for patients with chronic hepatitis B, positive with HBe antigen in young aged populationsChronic hepatitis BJPRN-UMIN000020124Division of Gastroenterology and Hepatology, Department of Internal Medicine, St. Marianna University School of Medicine,26
招募中
不适用
Randomized trial of new oral anti hepatitis B drug (entecavir) plus interferon versus another oral anti hepatitis B drug (lamivudine) plus interferon in chronic hepatitis B in children.CTRI/2016/04/006820jjal Poddar
招募中
不适用
Efficacy of entecavir-to-tenofovir switching treatment to attain a drug-free state in chronic hepatitis B: a randomized controlled trialchronic hepatitis BJPRN-UMIN000021793Department of Hepatology, Osaka Metropolitan University90
已完成
2 期
on-randomized clinical trial of the efficacy of entecavir and pegylated interferon in children with Hepatitis B Virus infectiochronic hepatitis B, HBVB181JPRN-jRCTs051180151Tajiri Hitoshi2